Stories by aaavl2821

At Silicon Valley’s debutante ball for startups, there’s more biology than ever

Researchers Repair a Mutation in Viable Human embryos with new crispr tech

Experienced biotech VCs and entrepreneurs talk about value creation

The mice with human tumours: Growing pains for a popular cancer model

The biggest obstacles to innovation in large companies

Why the Latest Alzheimer’s Drug Study Has So Many People Confused

Study Suggests Cannabis Can Make Schizophrenia Medication Less Effective

Think drug costs are bad? Try hospital prices

Why a $500M market cap biotech should be worth $0

For better data on Hispanics, Census may change how it asks about race (2017)

Prospectus from Hong Kong Exchange's First Biotech Mega-IPO [pdf]

On jadedness

Paralyzed mice with spinal cord injury made to walk again

Case Studies Where Phase 2 and Phase 3 Trials had Divergent Results [pdf]

Four Decades of Hacking Biotech and yet Biology Still Consumes Everything (2017)

Welcome to Right to Try

Gene therapy show promise for DMD

High resolution, label-free live cell imaging with Raman microscopy

New paper provides strong support for viral cause of Alzheimer's

The FDA is powerless to stop right-to-try profiteers

7 8 9 10 11 12 13 14